Heuron, a medical artificial intelligence company specializing in neurological diseases, said Tuesday that it has appointed Professor Ling Ling Chan from the Department of Radiology at Singapore General Hospital as a clinical advisor.
Professor Ling Ling Chan of Singapore General Hospital
Professor Chan is a world-renowned neuro-head and neck radiology expert, particularly in Parkinson's disease research. She is a senior consultant and clinical scientist at Singapore General Hospital, a professor at Duke-NUS Medical School, and vice chair of research at SingHealth Duke-NUS Academic Medical Center (AMC).
Chan is a researcher and physician who has published more than 200 research papers and is recognized for her research excellence in the academic community. She has an H-index of 37, which measures a researcher's scholarly output and impact.
Before joining the advisory board, Dr. Chan had used Heuron’s Parkinson’s disease solutions—Heuron IPD and Heuron NI—conducting multiple studies that highlighted their clinical potential and supported Heuron’s R&D.
On March 13, Dr. Chan spoke at Heuron's Parkinson's Leaders Forum, where she presented “SGH Experience on Nigrosome-1 Imaging and Heuron Parkinson's Solution at Singapore General Hospital” to a group of Korean neurologists and radiologists.
Heuron will continue to leverage Professor Chan's expertise in Parkinson's research and patient imaging to enhance its solutions, collaborate on research and publications, and promote clinical adoption.
The licensure of Heuron IPD in Singapore in February has accelerated Heuron's expansion into the Southeast Asian market. The company plans to work with Professor Chan to generate clinical evidence supporting its entry into the Singaporean payer market, a move it expects to drive broader global adoption.
“We are honored to have Professor Chan Ling Ling, one of the world's leading experts, as an advisor to Heuron Parkinson's Solutions,” Heuron CEO Shin Dong-hoon said. “This is an important opportunity for Heuron to take the next step forward. We will do our best to synergize with Professor Chan's outstanding research capabilities and experience to conduct quality research together.”